The primary efficacy variable was the change form baseline to the latest available evaluation in total lesion count. The primary efficacy result of this study clearly manifested the potency of TriCilest. [clinicaltrials_resource:e0506476557be10bc00787ea24526bda]
Comparison of efficacy and safety of Tricilest (norgestimate-ethinyl estradiol) and Diane-35 (cyproterone acetate-ethinyl estradiol) in the treatment of acne vulgaris
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
The primary efficacy variable was the change form baseline to the latest available evaluation in total lesion count. The primary efficacy result of this study clearly manifested the potency of TriCilest. [clinicaltrials_resource:e0506476557be10bc00787ea24526bda]
Comparison of efficacy and safety of Tricilest (norgestimate-ethinyl estradiol) and Diane-35 (cyproterone acetate-ethinyl estradiol) in the treatment of acne vulgaris
Bio2RDF identifier
e0506476557be10bc00787ea24526bda
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e0506476557be10bc00787ea24526bda
measure [clinicaltrials_vocabulary:measure]
The primary efficacy variable ...... sted the potency of TriCilest.
description
Comparison of efficacy and saf ...... the treatment of acne vulgaris
identifier
clinicaltrials_resource:e0506476557be10bc00787ea24526bda
title
The primary efficacy variable ...... sted the potency of TriCilest.
@en
type
label
The primary efficacy variable ...... 06476557be10bc00787ea24526bda]
@en